DexCom Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
160,000.00
259,200.00
402,000.00
573,300.00
718,500.00
1,032
Cost of Goods Sold (COGS) incl. D&A
59,900.00
82,900.00
114,600.00
169,900.00
208,000.00
368
Gross Income
100,100.00
176,300.00
287,400.00
403,400.00
510,500.00
664
SG&A Expense
126,500.00
197,800.00
335,500.00
442,300.00
525,400.00
845
EBIT
26,400.00
21,500.00
57,100.00
63,900.00
33,300.00
181
Unusual Expense
2,500.00
-
-
-
-
36
Non Operating Income/Expense
-
-
-
700.00
5,800.00
39
Interest Expense
900.00
800.00
400.00
700.00
12,800.00
23
Pretax Income
29,800.00
22,300.00
57,500.00
64,900.00
48,600.00
127
Income Tax
-
100.00
100.00
700.00
1,600.00
1
Consolidated Net Income
29,800.00
22,400.00
57,600.00
65,600.00
50,200.00
127
Net Income
29,800.00
22,400.00
57,600.00
65,600.00
50,200.00
127
Net Income After Extraordinaries
29,800.00
22,400.00
57,600.00
65,600.00
50,200.00
127
Net Income Available to Common
29,800.00
22,400.00
57,600.00
65,600.00
50,200.00
127
EPS (Basic)
0.42
0.30
0.72
0.78
0.58
1.44
Basic Shares Outstanding
71,100.00
75,200.00
79,800.00
83,600.00
86,300.00
88
EPS (Diluted)
0.42
0.30
0.72
0.78
0.58
1.44
Diluted Shares Outstanding
71,100.00
75,200.00
79,800.00
83,600.00
86,300.00
88
EBITDA
19,400.00
13,100.00
46,300.00
48,900.00
17,200.00
152
Other Operating Expense
-
-
9,000.00
25,000.00
18,400.00
-
Non-Operating Interest Income
-
-
-
400.00
3,300.00
2

About DexCom

View Profile
Address
6340 Sequence Drive
San Diego California 92121
United States
Employees -
Website http://www.dexcom.com
Updated 07/08/2019
DexCom, Inc. is a medical device manufacturing company, which engages in the design, development, and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G4 PLATINUM System, Dexcom studio and Mobile apps. The company was founded by John F.